Epidemiological studies suggest unique occurrence patterns of Hodgkin lymphoma (HL)
worldwide. In most Western countries there is a clear bimodal age distribution with an early …

Hodgkin lymphoma (HL) is a lymphatic malignancy with an estimated annual incidence of
80,000 cases world-wide. Modern therapy promises 5-year survival rates exceeding 90% for …

Hodgkin's lymphoma (HL) has a unique and distinct history, epidemiology, treatment, and
biology. A viral agent or infectious agent has long been considered as the etiologic agent …

The epidemiology of Hodgkin's Lymphoma (HL) varies with age at clinical onset. In
developing countries, the disorder appears predominantly during childhood and its …

Abstract Background The etiology of Hodgkin lymphoma (HL) remains incompletely
characterized. Studies of the association between smoking and HL have yielded ambiguous …

Epstein-Barr virus (EBV) has remained the main candidate suggested as the infection
causing Hodgkin's lymphoma for several years. However, EBV genome has been found only …

A bimodal age‐specific incidence pattern with a relatively high proportion of cases occurring
in adolescents and young adults is a hallmark of Hodgkin lymphoma (HL) epidemiology in …

Hodgkin lymphoma (HL) demonstrates heterogenous histologic findings, clinical
presentation, and outcomes. Using the United States Surveillance, Epidemiology, and End …

Hodgkin lymphoma (HL) has unique epidemiologic characteristics. The variation in
incidence according to age, sex, race, socioeconomic status, and histologic subtype …

Background Research has shown that ethnicity is a significant predictor of Hodgkin
lymphoma (HL). Variations in cancer incidence among ethnic groups in the same country …